In a recent Reuters article, GSK signs deal with sport’s World Anti-Doping Agency, Kate Kelland highlights the agreement between WADA and GlaxoSmithKline that allows GSK to “supply WADA with confidential information about medicines in early stage development that may be abused by athletes once licensed…” What this does is allow WADA to develop testing methods... Read more »